Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-09-01Clinical Trial Update: STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling [Phase 2]
Phase 2 study of STA-9090 (ganetespib) in castration-resistant prostate cancer was withdrawn. The trial included assessment of androgen rece…
-
CLINICAL_TRIALS withdrawal · 2015-04-20Clinical Trial Update: AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC) [Phase 2]
A Phase 2 clinical trial evaluating AMG 208 for the tumor microenvironment in metastatic castration-resistant prostate cancer has been withd…
-
CLINICAL_TRIALS withdrawal · 2014-07-23Clinical Trial Update: Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Phase Ib/II trial evaluating orteronel with itraconazole in men with castration-resistant prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-24Clinical Trial Update: Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients [Phase 1, Phase 2]
Phase I/II trial of ASP9521 in castration-resistant prostate cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2014-02-19Clinical Trial Update: Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
A Phase 2 study of G-202 for chemotherapy-naïve metastatic castration-resistant prostate cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-10-16Clinical Trial Update: Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating cabazitaxel in men aged 75 years or older with metastatic castration-resistant prostate cancer has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2013-09-27Clinical Trial Update: Oral Colchicine in Men With Castrate Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating oral colchicine in men with castration-resistant prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-17Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating enzalutamide in chemotherapy-naïve, symptomatic metastatic castration-resistant prostate cancer was withdrawn.